Nephrology Dialysis Transplantation

Foreword
pp. 1-1(1)
Authors: Cannata-Andía, J.; Passlick-Deetjen, J.; Ritz, E.

Molecular mechanisms of secondary hyperparathyroidism
pp. 2-7(6)
Author: Silver, J.

Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed
pp. 8-14(7)
Author: Ferreira, M.A.

Pathogenesis, prevention and management of low-bone turnover
pp. 15-17(3)
Authors: Cannata-Andía, J.B.

Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites
pp. 18-24(7)
Authors: Schömig, M.; Ritz, E.

Management of disturbed calcium metabolism in uraemic patients: 2. Indications for parathyroidectomy
pp. 25-29(5)
Authors: Schömig, M.; Ritz, E.

Management of disturbed calcium metabolism in uraemic patients: 3. Potential perspectives—calcimimetics
pp. 30-31(2)
Authors: Schömig, M.; Ritz, E.

Renal osteodystrophy: management of hyperphosphataemia
pp. 32-33(2)
Authors: Drüeke, T.B.

Calcium concentration in the dialysate and calcium supplements
pp. 34-35(2)
Author: Cunningham, J.

Role of hormone replacement in the management of osteoporosis in haemodialysed women: perspectives for the future
pp. 36-37(2)
Author: Weisinger, J.R.

Symbols and abbreviations used for the clinical algorithms
pp. 40-40(1)

Pathogenesis of renal osteodystrophy, natural history
pp. 41-42(2)

Management of Calcium-Phosphate metabolism in CRI-patients
pp. 43-44(2)

Management of calcium-phosphate metabolism in patients on dialysis (1)
pp. 45-46(2)

Management of calcium-phosphate metabolism in patients on dialysis (2)
pp. 47-48(2)

Management of hyperphosphataemic patients
pp. 49-50(2)

Management of hypercalcaemic patients
pp. 51-52(2)

When to Consider Parathyroidectomy
pp. 53-57(5)

Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management
pp. 58-68(11)
Author: Parfrey, P.S.

Cardiovascular disease in chronic renal failure: the challenge continues
pp. 69-80(12)
Authors: Locatelli, F.; Marcelli, D.; Conte, F.; D'Amico, M.; Del Vecchio, L.; Limido, A.; Malberti, F.; Spotti, D.

Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients
pp. 81-91(11)
Author: Massy, Z.A.

Importance of hyperlipidaemia and therapy in renal patients
pp. 92-96(5)
Author: Wanner, C.

Cardiovascular risk in end-stage renal disease: vascular aspects
pp. 97-104(8)
Authors: London, G.M.; Marchais, S.J.; Metivier, F.; Guerin, A.P.

Hypertension in chronic renal failure and end-stage renal disease patients treated with haemodialysis or peritoneal dialysis
pp. 105-110(6)
Author: Bianchi, G.

Cardiovascular problems in diabetic patients on renal replacement therapy
pp. 111-116(6)
Authors: Schömig, M.; Ritz, E.

Treatment of coronary artery disease in patients with renal failure
pp. 117-121(5)
Authors: de Jaegere, P.; Rabelink, T.J.; Truin, G.

Symbols and abbreviations used for the clinical algorithms
pp. 125-126(2)

Assessment of cardiovascular risk factors
pp. 127-128(2)

Management of dyslipidaemia
pp. 129-130(2)

General management of hypertension
pp. 131-132(2)

Antihypertensive management in non-diabetic CRI-patients
pp. 133-134(2)

Antihypertensive management in PD- and HD-patients
pp. 135-136(2)

Management of diabetic patients with microalbuminuria
pp. 137-138(2)

Management of patients with diabetic nephropathy
pp. 139-140(2)

Management of diabetic patients on dialysis
pp. 141-142(2)

Management of acute ischaemic heart disease
pp. 143-144(2)

Management of chronic ischaemic heart disease
pp. 145-146(2)

Management of heart failure
pp. 147-148(2)

Microinflammatory state in CRI, PD-/HD-patients
pp. 149-154(6)

ACE inhibitors and AT₁ receptor antagonists—beyond the haemodynamic effect
pp. 561-565(5)
Authors: Ruiz-Ortega, Marta; Lorenzo, Oscar; Ruperez, Monica

Use of corticosteroids in nephrology — risk and prevention of osteoporosis induction
pp. 565-568(4)
Author: Jehle, Peter M.

Great strides in the understanding of renal magnesium and calcium reabsorption
pp. 568-571(4)
Authors: Monnens, Leo; Starremans, Patrick

Clostridium difficile in patients with renal failure — management of an outbreak using biotherapy
pp. 571-574(4)
Authors: Swann, A.; Popoola, J.; Warwick, G.

Blood monocyte phenotypes and soluble endotoxin receptor CD14 in systemic inflammatory diseases and patients with chronic renal failure
pp. 574-578(5)
Author: Scherberich, Juergen E.

Water quality and complications of haemodialysis
pp. 578-580(3)
Author: Brunet, Philippe

Calcium channel blockers – the effect on renal changes in clinical and experimental diabetes: an overview
pp. 581-585(5)
Author: Nielsen, Birgitte

G^-699/C polymorphism in the bradykinin-1 receptor gene in patients with renal failure
pp. 586-588(3)
Authors: Knigge, Heidrun; Blüthner, Martin; Brüntgens, Angelika; Sator, Heike

Glial cell line-derived neurotrophic factor (GDNF) is expressed in the human kidney and is a growth factor for human mesangial cells
pp. 589-595(7)
Authors: Orth, Stephan R.; Ritz, Eberhard

TGF-₁ down-regulates inflammatory cytokine-induced VCAM-1 expression in cultured human glomerular endothelial cells
pp. 596-604(9)
Authors: Park, Su-Kil; Yang, Won Seok; Lee, Sang Koo; Ahn, Hanjong; Park, Jung Sik; Hwang, Onyou

Hypomagnesaemia–hypercalciuria–nephrocalcinosis: a report of nine cases and a review
pp. 605-610(6)
Authors: Benigno, Vincenzo; Canonica, Claudia S.; Bettinelli, Alberto; von Vigier, Rodo O.; Truttmann, Anita C.

Wegener's granulomatosis: clinical course in 108 patients with renal involvement
pp. 611-618(8)
Authors: Aasarød, Knut; Iversen, Bjarne M.; Hammerstrøm, Jens; Bostad, Leif; Vatten, Lars

Synthesis of immunoglobulins against Haemophilus parainfluenzae by tonsillar lymphocytes from patients with IgA nephropathy
pp. 619-624(6)
Authors: Suzuki, Satoru; Fujieda, Shigeharu; Sunaga, Hiroshi; Yamamoto, Chie; Kimura, Hideki

Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy
pp. 625-630(6)
Authors: Tarnow, Lise; Stehouwer, Coen D. A.; Emeis, Jef J.; Poirier, Odette; Cambien, François; Hansen, Birgitte V.

Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease
pp. 631-636(6)
Authors: Suresh, Mathavakkannan; Laboi, Paul; Mamtora, Hari

Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function
pp. 637-643(7)
Authors: van Paassen, Pieter; de Zeeuw, Dick; Navis, Gerjan; de Jong, Paul E.

Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients?
pp. 644-649(6)
Authors: Schreiner, Oliver; Wandel, Eveline; Himmelsbach, Frido; Galle, Peter R.

Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study
pp. 650-658(9)
Author: Holland, David C.

A new assay method that detects only intact osteocalcin. Two-step non-invasive diagnosis to predict adynamic bone disease in haemodialysed patients
pp. 659-667(9)
Authors: Morishita, T.; Nomura, M.; Hanaoka, M.; Saruta, T.; Matsuo, T.; Tsukamoto, Y.

Low free thyroxine concentratios and deficient nocturnal surge of thyroid-stimulating hormone in haemodialysed patients compared with undialysed patients
pp. 668-672(5)
Authors: Nakajima, T.; Suzuki, T.; Ando, S.; Genma, R.; Nakamura, H.; Hishida, A.; Yonemura, K.

Variability of relative blood volume during haemodialysis
pp. 673-679(7)
Authors: Krepel, Harmen P.; Nette, Robert W.; Akçahüseyin, Emin; Weimar, Willem

Gel clot LAL assay in the initial management of peritoneal dialysis patients with peritonitis: a retrospective study
pp. 680-683(4)
Authors: Hausmann, Michael J.; Yulzari, Robert; Lewis, Eli; Saisky, Yaniv

Effects of atorvastatin on dyslipidaemia in uraemic patients on peritoneal dialysis
pp. 684-688(5)
Authors: Hufnagel, Gilles; Michel, Catherine; Vrtovsnik, François; Queffeulou, Guillaume; Kossari, Niloufar

A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor
pp. 689-695(7)
Authors: Oka, Kazumasa; Imai, Enyu; Moriyama, Toshiki; Akagi, Yoshitaka; Ando, Akio; Hori, Masatsugu; Okuyama, Akihiko; Toki, Kiyohide; Kyo, Masahiro; Kokado, Yukito

Age-matching in renal transplantation
pp. 696-700(5)
Authors: Waiser, Johannes; Schreiber, Matthias; Budde, Klemens; Fritsche, Lutz; Böhler, Torsten; Hauser, Ingeborg

Survival of patients who have been on a waiting list for renal transplantation
pp. 701-704(4)
Authors: Medin, Charlotte; Elinder, Carl-Gustaf; Hylander, Britta; Blom, Birgit

Adverse effect of donor arteriolosclerosis on graft outcome after renal transplantation
pp. 705-710(6)
Authors: Pokorná, Eva; Vítko, tefan; Chadimová, Maria

The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation
pp. 711-714(4)
Authors: ter Meulen, Cornelis G.; Wetzels, Jack F. M.

Baclofen unerotoxicity in a chronic haemodialysis patient
pp. 715-716(2)
Authors: Bassilios, Nader; Launay-Vacher, Vincent; Mercadal, Lucile

Concurrent pheochromocytoma, diabetes insipidus and cerebral venous thrombosis—a possible unique pathophysiological mechanism
pp. 717-718(2)
Authors: Stella, Paola; Bignotti, Giancarlo; Zerbi, Simona; Ciurlino, Daniele; Landoni, Claudio; Fazio, Ferruccio

Unsuspected cardiac tamponade following insertion of a haemodialysis catheter: a normal chest radiograph does not exclude a complication
pp. 719-721(3)
Authors: Ho, Timothy B. L.; Cusack, Rebecca; Rhodes, Andrew

Implantation of a new device for haemodialysis
pp. 722-724(3)
Authors: Buerger, Thomas; Gebauer, Thomas; Meyer, Frank

Green urine after motorcycle accident
pp. 725-726(2)
Authors: Lepenies, Julia; Toubekis, Evjenia; Frei, Ulrich

The patient who had a picnic at a waterfall and presented with haemoptysis and renal failure
pp. 727-728(2)
Author: Thiruventhiran, T.

Beware backache in chronic dialysis patients
pp. 729-730(2)
Authors: Amir-Ansari, Behzad; Negus, Samantha; Cairns, Hugh

Pulmonary, cardiac and renal syndrome
pp. 731-732(2)
Authors: Gleadle, Jonathan M.; Davies, David

Unexplained haematuria
pp. 734-735(2)

Clearance of an oral delayed-release mesalazine preparation (Salofalk^®) by haemodialysis—pharmacokinetic profile of mesalazine related to the effects of dialysis
pp. 736-738(3)
Authors: Verzijl, J. M.; Kamphuis, Th. J.; Rensma, P. L.

Can antihypertensive medications control BP in haemodialysis patients
pp. 736-736(1)

Long-term efficacy of lipoprotein apheresis in homozygous familial hypercholesterolaemia
pp. 738-740(3)
Author: Meier, Pascal

Renal terminology
pp. 738-738(1)

Influenza vaccine—a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate
pp. 740-741(2)
Authors: Plotkin, Eleanora; Bernheim, Jacques; Ben-Chetrit, Sydney; Mor, Adam

Acute renal failure after transarterial chemoembolization progressing to chronic renal failure in hepatocellular carcinoma
pp. 741-742(2)
Authors: Kim, M-J.; Lee, S.W.; Kim, G.A.; Song, J.H.

The beneficial effect of a journalist's death on organ transplantation and hepatitis B vaccination
pp. 742-743(2)
Author: Akpolat, Tekin

Isolated tuberculous pyomyositis in a renal transplant patient
pp. 743-743(1)
Author: Johnson, David W.